Shots:

• The survey enrolled 300 (US respondents) psoriasis patients are interested in additional benefits i.e. no. of years of proven efficacy and safety with no injection site reactions in addition to clear skin
• Survey also indicated that efficacy of drug in treating multiple manifestations of psoriatic disease was also important for patients while no. of injections per dose and their frequency was less preferred in patients
• This online DCE survey is aimed to help dermatologists understand patient’s preference for five selected attributes differentiating biologic treatments from moderate-to-severe plaque psoriasis

/ article | Ref: Novartis | Image: Wall Street